Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

Mumbai: Pharmaceutical giants Cipla and Alkem Laboratories are in the final stages of a bidding war to acquire a controlling ...

DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications: Gireesh Babu, New Delhi Thursday, October 17, 2024, 08:00 Hrs [IST] The Departme ...

On Friday, September 27, some Indian pharma shares are soaring, while others struggle to hold onto the green territory. One ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

Citi’s commentary comes as China-based pharma company Jiangsu Hengrui has received approval for Paclitaxel, the generic ...

Citi Maintains Buy On Cipla | Goa Unit Warning Letter Under Scanner#cipla #ciplastocks #brokerageradar #citi #businessnews ...

Investec emphasised the significant potential Cipla holds in the GLP-1 (Glucagon-like peptide) space, a hormone crucial for ...

Cipla’s stock remains in a strong uptrend despite recent dips, with potential to rise to ₹1,800-₹1,850 this quarter and ...

India's largest stent manufacturer, Sahajanand Medical Technologies is also reportedly exploring a public listing on the domestic market ...